Evidence map›Paper›PMID 27457811›Full record

ArticleMolecular psychiatry2017

Rare DNA variants in the brain-derived neurotrophic factor gene increase risk for attention-deficit hyperactivity disorder: a next-generation sequencing study.

Z Hawi, T D R Cummins, J Tong, M Arcos-Burgos, Q Zhao, N Matthews, D P Newman, B Johnson, A Vance, H S Heussler and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Evaluation of the Relationship BetweenFrontiers in psychiatry · 2022
    Pooled it
  2. Shared genetic background between children and adults with attention deficit/hyperactivity disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. ADHD: Reviewing the Causes and Evaluating Solutions.Journal of personalized medicine · 2021
    Review
  12. Article
  13. Article
  14. From man to fly - convergent evidence links FBXO25 to ADHD and comorbid psychiatric phenotypes.Journal of child psychology and psychiatry, and allied disciplines · 2020
    Article
  15. Article
  16. Review
  17. Review
  18. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2018
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Z HawiSchool of Psychological Sciences and Monash Institute for Cognitive and Clinical Neurosciences (MICCN), Monash University, Melbourne, VIC, Australia.
T D R CumminsSchool of Psychological Sciences and Monash Institute for Cognitive and Clinical Neurosciences (MICCN), Monash University, Melbourne, VIC, Australia.
J TongSchool of Psychological Sciences and Monash Institute for Cognitive and Clinical Neurosciences (MICCN), Monash University, Melbourne, VIC, Australia.ORCID 0000-0002-3269-1438
M Arcos-BurgosJohn Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
Q ZhaoQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-6341-0416
N MatthewsQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
D P NewmanSchool of Psychological Sciences and Monash Institute for Cognitive and Clinical Neurosciences (MICCN), Monash University, Melbourne, VIC, Australia.
B JohnsonSchool of Psychological Sciences and Monash Institute for Cognitive and Clinical Neurosciences (MICCN), Monash University, Melbourne, VIC, Australia.
A VanceAcademic Child Psychiatry Unit, Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Melbourne, VIC, Australia.
H S HeusslerMater Research Institute, University of Queensland, Brisbane, QLD, Australia.
F LevySchool of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
S EastealJohn Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
N R WrayQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0001-7421-3357
E KennyNeuropsychiatric Genetics Research Group, Department of Psychiatry and Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland.
D MorrisDepartment of Biochemistry, National University of Ireland Galway, Galway, Ireland.ORCID 0000-0002-3413-570X
L KentSchool of Medicine, University of St Andrews, St Andrews, Scotland, UK.
M GillNeuropsychiatric Genetics Research Group, Department of Psychiatry and Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0003-0206-5337
M A BellgroveSchool of Psychological Sciences and Monash Institute for Cognitive and Clinical Neurosciences (MICCN), Monash University, Melbourne, VIC, Australia.
Monash University · AUThe University of Queensland · AUAustralian National University · AUTrinity College Dublin · IEOllscoil na Gaillimhe – University of Galway · IERoyal Children's Hospital · AUUniversity of St Andrews · GBUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a prevalent and highly heritable disorder of childhood with negative lifetime outcomes. Although candidate gene and genome-wide association studies have identified promising common variant signals, these explain only a fraction of the heritability of ADHD. The observation that rare structural variants confer substantial risk to psychiatric disorders suggests that rare variants might explain a portion of the missing heritability for ADHD. Here we believe we performed the first large-scale next-generation targeted sequencing study of ADHD in 152 child and adolescent cases and 188 controls across an a priori set of 117 genes. A multi-marker gene-level analysis of rare (<1% frequency) single-nucleotide variants (SNVs) revealed that the gene encoding brain-derived neurotrophic factor (BDNF) was associated with ADHD at Bonferroni corrected levels. Sanger sequencing confirmed the existence of all novel rare BDNF variants. Our results implicate BDNF as a genetic risk factor for ADHD, potentially by virtue of its critical role in neurodevelopment and synaptic plasticity.

Indexed as

AdolescentAttention Deficit Disorder with HyperactivityBrain-Derived Neurotrophic FactorCase-Control StudiesChildDNAFemaleGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyGenotypeHigh-Throughput Nucleotide SequencingHumansIrelandMalePolymorphism, Single NucleotideBDNF protein, humanBrain-Derived Neurotrophic FactorDNA

Identifiers

PMID27457811
OpenAlexW2485419961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.